Lansoprazole-induced improvement of esophageal submucosal injury

Journal of Clinical Biochemistry and Nutrition

Volumn 41, Issue 2, 2007, Pages 92-96

  Mine, Shinichiro ^a   Tanaka, Yoshiya ^b  

^a Hagiwara Central Hospital   (Japan)

^b UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Endoscopic ultrasonography; Esophageal wall structure; GERD; Lansoprazole

Indexed keywords

FAMOTIDINE; LANSOPRAZOLE; PROTON PUMP INHIBITOR;

CYTOKINE RELEASE; DOSE RESPONSE; DRUG EFFICACY; DUODENUM ULCER; ESOPHAGUS MOTILITY; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; HISTOPATHOLOGY; HUMAN; INFLAMMATION; REVIEW; STOMACH ULCER; TRANSMISSION ELECTRON MICROSCOPY;

EID: 34948818125     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.2007013     Document Type: Review

References (35)

1. Vakil, N., van Zaten, S.V., Kahrilas, P., Dent, J., and Jones, R.: the Global Consensus Group: The montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am. J. Gastroenterol., 101, 1900-1920, 2006.
2. Havelund, T., Lind, T., Wiklund, I., Glise, H., Hernqvist, H., Lauritsen, K., Lundell, L., Pedersen, S.A., Carlson, R., Junghard, O., Stubberod, A., and Anker-Hansen, O.: Quality of life in patients with heartburn but without esophagitis: effects of treatment with omeprazole. Am. J. Gastroenterol., 94, 1782-1789, 1999.
3. Lagergren, J., Bergstrom, R., Lindgren, A., and Nyren, O.: Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N. Engl. J. Med., 340, 825-831, 1999.
4. Locke, G.R., Tally, N.J., Fett, S.L., Zinsmeister, A.R., and Melton, L.J.: Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted Country, Minnesota. Gastroenterology, 112, 1448-1456, 1997.
5. Orland, R.C.: Reflux esophagitis, in Textbook of gastroenterology, eds. By Yamada, T., Alpers, D.H., Owyang, C., Powell, D.W., and Laine, L., Lippincott Williams & Wilkins, Philadelphia, pp. 1235-1263, 1999.
6. Martinez, S.D., Malagon, I.B., Garewal, H.S., Cui, H., and Fass, R.: Non-erosive reflux disease (NERD) - acid reflux and symptom patterns. Aliment. Pharmacol. Ther., 17, 537-545, 2003.
7. Fass, R.: Epidemiology and pathophysiology of symptomatic gastroesophageal reflux disease. Am. J. Gastroenterol., 98 Suppl, S2-S7, 2003.
8. Tack, J., Talley, N.J., Camilleri, M., Holtmann, G., Hu, P., Malagelada, J.-R., and Stanghellini, V.: Functional esophageal disorders. Gastroenterology, 130, 1459-1479, 2006.
9. Spencer, C.M. and Faulds, D.: Lansoprazole: A reappraisal of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy in acid-related disorders. Drugs, 48, 404-430, 1994.
10. Petite, J-P., Slama, J-L., Licht, H., Lemerez, M., Coste, T., Andrieu, J., Grimaud, J.C., Julien, H., Dupuis, J., and Sallerin, V.: Comparison of Lansoprazole (30 mg) and omeprazole (20 mg) in the treatment of duodenal ulcers: A multicentric double-blind comparative trial. Gastroenterol. Clin. Biol., 17, 334-340, 1993.
11. Florent, C., Forestier, S., and Joubert-Collin, M.: Lansoprazole versus omeprazole: Efficacy and safety in acute gastric ulcer. Gastroenterology, 104 Suppl, A80, 1993.
12. 2-receptor antagonist therapy. Am. J. Gastroenterol., 92, 429-437, 1997.
13. Calabrese, C., Fabbri, A., Bortolotti, M., Cenacchi, G., Areni, A., Scialpi, C., Miglioli, M., and Di Febo, G.: Dilated intercellular spaces as a marker of oesophageal damage: comparative results in gastro-oesophageal reflux disease with or without bile reflux. Aliment. Pharmacol. Ther., 18, 525-532, 2003.
14. Tobey, N.A., Carson, J.L., Alkiek, R.A., and Orlando, R.C.: Dilated intercellular spaces: A morphological feature of acid reflux-damaged human esophageal epithelium. Gastroenterology, 111, 1200-1205, 1996.
15. Kiesslich, R., Kanzler, S., Vieth, M., Moehler, M., Neidig, J., Thanka Nadar, B.J., Schlling, D., Burg, J., Nafe, B., Neurath, M.F., and Galle, P.R.: Minimal change esophagitis: prospective comparison of endoscopic and histological makers between patients with non-erosive reflux disease and normal controls using magnifying endoscopy. Dig. Dis., 22, 221-227, 2004.
16. Tobey, N.A., Hosseini, S.S., Argote, C.M., Dobrucali, A.M., Awayda, M.S., and Orlando, R.C.: Dilated intercellular spaces and shunt permeability in nonerosive acid-damaged esophageal epithelium. Am. J. Gastroenterol., 99, 13-22, 2004.
17. Caletti, G.C., Bolondi, L., Zani, L., and Labo, G.: Technique of endoscopic ultrasonography investigation: esophagus, stomach and duodenum. Scand. J. Gastroenterol., 21 Suppl 123, 1-5, 1986.
18. Tsukamoto, Y., Goto, H., Hase, S., Niwa, Y., Arisawa, T., Hayakawa, T., and Yoshikane, H.: Endosonographic evaluation of the quality of ulcer healing induced by proton pump inhibitors. J. Clin. Gastroenterol., 20 Suppl 2, S40-S43, 1995.
19. Caletti, G.C., Fusaroli, P., and Bocus, P.: Endoscopic ultrasonography. Digestion, 59, 509-529, 1998.
20. Caletti, G.C., Ferrari, A., Mattioli, S., Zannoli, R., Di Simone, M.P., Bocus, P., Gozzetti, G., and Barbara, L.: Endoscopy versus endoscopic ultrasonography in staging reflux esophagitis. Endoscopy, 26, 794-797, 1994.
21. Mine, S., Fujisaki, T., Tabata, T., Matsuoka, H., Iida, T., Yamada, S., Tanaka, Y., Morimoto, I., Eto, S., and Aibe, T.: Ultrasonographic evaluation of lansoprazole-induced improvement of submucosal injury in patients with gastroesophageal reflux. Am. J. Gastroenterol., 95, 381-386, 2000.
22. Sato, H., Murayama, I., Suda, K., Takeya, K., Tanaka, T., Takeuchi, M., and Kohashi, E.: Endoscopic ultrasonography for reflux esophagitis. Stomach and Intestine, 27, 1047-1051, 1992.
23. Kawamura, O., Sekiguchi, T., Kusano, M., Horikoshi, T., Kikuchi, K., Miyazaki, M., Yamada, T., and Ohwada, T.: Endoscopic ultrasonographic abnormalities and lower esophageal sphincter function in reflux esophagitis. Dig. Dis. Sci., 40, 598-605, 1995.
24. Pehlivanov, N., Liu, J., Kassab, G.S., Puckert, J.L., and Mittal, R.K.: Relationship between esophageal muscle thickness and intraluminal pressure: an ultrasonographic study. Am. J. Physiol. Gastrointest. Liver. Physiol., 280, G1093-G1098, 2001.
25. Barlow, W.J. and Orlando, R.C.: The pathogenesis of heart-burn in nonerosive reflux disease: a unifying hypothesis. Gastroenterology, 128, 771-778, 2005.
26. Pehlivanov, N., Liu, J., and Mittal, R.K.: Sustained esophageal contraction: a motor correlate of heartburn symptom. Am. J. Physiol. Gastrointest. Liver. Physiol., 280, G743-G751, 2001.
27. Balaban, D.H., Yamamoto, Y., Liu, J., Pehlivanov, N., Wisniewski, R., DeSilvey, D., and Mittal, R.K.: Sustained esophageal contraction: a marker of esophageal chest pain identified by intraluminal ultrasonography. Gastroenterology, 116, 29-37, 1999.
28. Howden, C.W., Henning, J.M., Huang, B., Lukasik, N., and Freston, J.W.: Management of heartburn in a large, randomized, community-based study: comparison of four therapeutic strategies. Am. J. Gastroenterol., 96, 1704-1710, 2001.
29. Richter, J.E., Kovacs, T.O.G., Greski-rose, P.A., Huang, B., and Fisher, R.: Lansoprazole in the treatment of heartburn in patients without erosive oesophagitis. Aliment. Pharmacol. Ther., 13, 795-804, 1999.
30. Galmiche, J.P., Barthelemy, P., and Hamelin, B.: Treating the symptoms of gastro-oesophageal reflux disease: a double-blind comparison of omeprazole and cisapride. Aliment. Pharmacol. Ther., 11, 765-773, 1997.
31. Mine, S., Iida, T., Tabata, T., Kishikawa, H., and Tanaka, Y.: Management of symptoms in step-down therapy of gastroesophageal reflux disease. J. Gastroenterol. Hepatol., 20, 1365-1370, 2005.
32. Schindlbeck, N.E., Weibecke, B., Klauser, A.G., Voderholzer, W.A., and Muller-Lissner, S.A.: Diagnostic value of histology in non-erosive gastroesophageal reflux disease. Gut, 39, 151-154, 1996.
33. Calabrese, C., Bortolotti, M., Fabbri, A., Areni, A., Cenacchi, G., Scialpi, C., Miglioli, M., and Di Febo, G.: Reversibility of GERD ultrastructural alterations and relief of symptoms after omeprazole treatment. Am. J. Gastroenterol., 100, 537-542, 2005.
34. Aydin, C., Sarac, B., Koyuncu, A., Yildirim, S., Sen, M., and Sarioglu, Y.: Relaxant effect of omeprazole and lansoprazole in guinea pig gallbladder muscle strips in vitro. J. Gastroenterol., 38, 765-771, 2003.
35. Naseri, E. and Yenisehirli, A.: Proton pump inhibitors omeprazole and lansoprazole induce relaxation of isolated human arteries. Eur. J. Pharmacol., 531, 226-231, 2006.